nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Dactinomycin—sarcoma	0.168	0.289	CbGbCtD
Scopolamine—ABCB1—Mitoxantrone—sarcoma	0.15	0.259	CbGbCtD
Scopolamine—ABCB1—Vincristine—sarcoma	0.103	0.178	CbGbCtD
Scopolamine—ABCB1—Etoposide—sarcoma	0.0946	0.163	CbGbCtD
Scopolamine—ABCB1—Doxorubicin—sarcoma	0.0645	0.111	CbGbCtD
Scopolamine—Abdominal cramps—Vincristine—sarcoma	0.0094	0.0224	CcSEcCtD
Scopolamine—Photophobia—Thiotepa—sarcoma	0.00672	0.016	CcSEcCtD
Scopolamine—Urinary retention—Thiotepa—sarcoma	0.00494	0.0118	CcSEcCtD
Scopolamine—Dysphagia—Dactinomycin—sarcoma	0.00446	0.0106	CcSEcCtD
Scopolamine—Urinary retention—Vincristine—sarcoma	0.00438	0.0104	CcSEcCtD
Scopolamine—Redness—Epirubicin—sarcoma	0.00427	0.0102	CcSEcCtD
Scopolamine—Dysuria—Thiotepa—sarcoma	0.0042	0.00999	CcSEcCtD
Scopolamine—Muscular weakness—Vincristine—sarcoma	0.00406	0.00967	CcSEcCtD
Scopolamine—Redness—Doxorubicin—sarcoma	0.00395	0.0094	CcSEcCtD
Scopolamine—Conjunctivitis—Thiotepa—sarcoma	0.00389	0.00926	CcSEcCtD
Scopolamine—Amblyopia—Epirubicin—sarcoma	0.00373	0.00888	CcSEcCtD
Scopolamine—Dysuria—Vincristine—sarcoma	0.00372	0.00886	CcSEcCtD
Scopolamine—Hallucination—Thiotepa—sarcoma	0.00358	0.00851	CcSEcCtD
Scopolamine—Urinary tract disorder—Thiotepa—sarcoma	0.00355	0.00845	CcSEcCtD
Scopolamine—Pharyngitis—Dactinomycin—sarcoma	0.00354	0.00843	CcSEcCtD
Scopolamine—Urethral disorder—Thiotepa—sarcoma	0.00352	0.00839	CcSEcCtD
Scopolamine—Drowsiness—Mitoxantrone—sarcoma	0.00346	0.00823	CcSEcCtD
Scopolamine—Amblyopia—Doxorubicin—sarcoma	0.00345	0.00822	CcSEcCtD
Scopolamine—Sweating—Vincristine—sarcoma	0.0034	0.0081	CcSEcCtD
Scopolamine—Conjunctivitis—Mitoxantrone—sarcoma	0.00336	0.008	CcSEcCtD
Scopolamine—Eye disorder—Thiotepa—sarcoma	0.00336	0.00799	CcSEcCtD
Scopolamine—Sweating—Mitoxantrone—sarcoma	0.00331	0.00789	CcSEcCtD
Scopolamine—Flushing—Dactinomycin—sarcoma	0.00331	0.00788	CcSEcCtD
Scopolamine—Dysphagia—Etoposide—sarcoma	0.00323	0.00768	CcSEcCtD
Scopolamine—Arrhythmia—Thiotepa—sarcoma	0.00321	0.00764	CcSEcCtD
Scopolamine—Hallucination—Vincristine—sarcoma	0.00317	0.00755	CcSEcCtD
Scopolamine—Bradycardia—Mitoxantrone—sarcoma	0.00316	0.00752	CcSEcCtD
Scopolamine—Mental disorder—Thiotepa—sarcoma	0.00315	0.00749	CcSEcCtD
Scopolamine—Urinary tract disorder—Vincristine—sarcoma	0.00315	0.00749	CcSEcCtD
Scopolamine—Erythema—Thiotepa—sarcoma	0.00313	0.00745	CcSEcCtD
Scopolamine—Urethral disorder—Vincristine—sarcoma	0.00312	0.00744	CcSEcCtD
Scopolamine—Erythema—Dactinomycin—sarcoma	0.00311	0.00739	CcSEcCtD
Scopolamine—Pharyngitis—Mitoxantrone—sarcoma	0.00308	0.00733	CcSEcCtD
Scopolamine—Vision blurred—Thiotepa—sarcoma	0.00295	0.00702	CcSEcCtD
Scopolamine—Agitation—Thiotepa—sarcoma	0.00288	0.00684	CcSEcCtD
Scopolamine—Mental disorder—Vincristine—sarcoma	0.00279	0.00665	CcSEcCtD
Scopolamine—Arrhythmia—Mitoxantrone—sarcoma	0.00277	0.0066	CcSEcCtD
Scopolamine—Erythema—Mitoxantrone—sarcoma	0.0027	0.00643	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—sarcoma	0.00266	0.00633	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00265	0.0063	CcSEcCtD
Scopolamine—Confusional state—Thiotepa—sarcoma	0.00257	0.00613	CcSEcCtD
Scopolamine—Urinary tract disorder—Etoposide—sarcoma	0.00255	0.00607	CcSEcCtD
Scopolamine—Agitation—Vincristine—sarcoma	0.00255	0.00607	CcSEcCtD
Scopolamine—Vision blurred—Mitoxantrone—sarcoma	0.00255	0.00606	CcSEcCtD
Scopolamine—Oedema—Dactinomycin—sarcoma	0.00253	0.00603	CcSEcCtD
Scopolamine—Urethral disorder—Etoposide—sarcoma	0.00253	0.00602	CcSEcCtD
Scopolamine—Nervous system disorder—Thiotepa—sarcoma	0.0025	0.00596	CcSEcCtD
Scopolamine—Vertigo—Vincristine—sarcoma	0.00249	0.00593	CcSEcCtD
Scopolamine—Tachycardia—Thiotepa—sarcoma	0.00249	0.00593	CcSEcCtD
Scopolamine—Skin disorder—Thiotepa—sarcoma	0.00248	0.0059	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—sarcoma	0.00246	0.00586	CcSEcCtD
Scopolamine—Eye disorder—Etoposide—sarcoma	0.00241	0.00574	CcSEcCtD
Scopolamine—Flushing—Etoposide—sarcoma	0.0024	0.0057	CcSEcCtD
Scopolamine—Eczema—Epirubicin—sarcoma	0.00233	0.00554	CcSEcCtD
Scopolamine—Somnolence—Thiotepa—sarcoma	0.00227	0.0054	CcSEcCtD
Scopolamine—Oedema—Vincristine—sarcoma	0.00226	0.00539	CcSEcCtD
Scopolamine—Confusional state—Mitoxantrone—sarcoma	0.00222	0.00529	CcSEcCtD
Scopolamine—Nervous system disorder—Vincristine—sarcoma	0.00222	0.00528	CcSEcCtD
Scopolamine—Oedema—Mitoxantrone—sarcoma	0.00221	0.00525	CcSEcCtD
Scopolamine—Fatigue—Thiotepa—sarcoma	0.0022	0.00524	CcSEcCtD
Scopolamine—Hyperhidrosis—Vincristine—sarcoma	0.00219	0.00521	CcSEcCtD
Scopolamine—Fatigue—Dactinomycin—sarcoma	0.00219	0.0052	CcSEcCtD
Scopolamine—Constipation—Thiotepa—sarcoma	0.00218	0.0052	CcSEcCtD
Scopolamine—Pain—Thiotepa—sarcoma	0.00218	0.0052	CcSEcCtD
Scopolamine—Pain—Dactinomycin—sarcoma	0.00217	0.00516	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—sarcoma	0.00215	0.00513	CcSEcCtD
Scopolamine—Tachycardia—Mitoxantrone—sarcoma	0.00215	0.00512	CcSEcCtD
Scopolamine—Skin disorder—Mitoxantrone—sarcoma	0.00214	0.0051	CcSEcCtD
Scopolamine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00213	0.00507	CcSEcCtD
Scopolamine—Hypotension—Vincristine—sarcoma	0.00212	0.00504	CcSEcCtD
Scopolamine—Feeling abnormal—Thiotepa—sarcoma	0.0021	0.00501	CcSEcCtD
Scopolamine—Feeling abnormal—Dactinomycin—sarcoma	0.00209	0.00497	CcSEcCtD
Scopolamine—Hypotension—Mitoxantrone—sarcoma	0.00206	0.0049	CcSEcCtD
Scopolamine—Vertigo—Etoposide—sarcoma	0.00202	0.00481	CcSEcCtD
Scopolamine—Abdominal pain—Thiotepa—sarcoma	0.00202	0.0048	CcSEcCtD
Scopolamine—Body temperature increased—Thiotepa—sarcoma	0.00202	0.0048	CcSEcCtD
Scopolamine—Abdominal pain—Dactinomycin—sarcoma	0.002	0.00477	CcSEcCtD
Scopolamine—Body temperature increased—Dactinomycin—sarcoma	0.002	0.00477	CcSEcCtD
Scopolamine—Somnolence—Mitoxantrone—sarcoma	0.00196	0.00467	CcSEcCtD
Scopolamine—Fatigue—Vincristine—sarcoma	0.00195	0.00465	CcSEcCtD
Scopolamine—Pain—Vincristine—sarcoma	0.00194	0.00461	CcSEcCtD
Scopolamine—Constipation—Vincristine—sarcoma	0.00194	0.00461	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—sarcoma	0.00192	0.00456	CcSEcCtD
Scopolamine—Fatigue—Mitoxantrone—sarcoma	0.0019	0.00452	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.0019	0.00452	CcSEcCtD
Scopolamine—Constipation—Mitoxantrone—sarcoma	0.00189	0.00449	CcSEcCtD
Scopolamine—Pain—Mitoxantrone—sarcoma	0.00189	0.00449	CcSEcCtD
Scopolamine—Confusional state—Etoposide—sarcoma	0.00185	0.0044	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—sarcoma	0.00185	0.00439	CcSEcCtD
Scopolamine—Asthenia—Thiotepa—sarcoma	0.00183	0.00436	CcSEcCtD
Scopolamine—Asthenia—Dactinomycin—sarcoma	0.00182	0.00433	CcSEcCtD
Scopolamine—Feeling abnormal—Mitoxantrone—sarcoma	0.00182	0.00432	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—sarcoma	0.00181	0.0043	CcSEcCtD
Scopolamine—Pruritus—Thiotepa—sarcoma	0.00181	0.0043	CcSEcCtD
Scopolamine—Tachycardia—Etoposide—sarcoma	0.00179	0.00426	CcSEcCtD
Scopolamine—Abdominal pain—Vincristine—sarcoma	0.00179	0.00426	CcSEcCtD
Scopolamine—Body temperature increased—Vincristine—sarcoma	0.00179	0.00426	CcSEcCtD
Scopolamine—Skin disorder—Etoposide—sarcoma	0.00178	0.00424	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—sarcoma	0.00177	0.00422	CcSEcCtD
Scopolamine—Hyperhidrosis—Etoposide—sarcoma	0.00177	0.00422	CcSEcCtD
Scopolamine—Abdominal pain—Mitoxantrone—sarcoma	0.00174	0.00415	CcSEcCtD
Scopolamine—Body temperature increased—Mitoxantrone—sarcoma	0.00174	0.00415	CcSEcCtD
Scopolamine—Hypotension—Etoposide—sarcoma	0.00171	0.00408	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—sarcoma	0.00171	0.00406	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—sarcoma	0.00169	0.00402	CcSEcCtD
Scopolamine—Dizziness—Thiotepa—sarcoma	0.00169	0.00402	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—sarcoma	0.00167	0.00398	CcSEcCtD
Scopolamine—Somnolence—Etoposide—sarcoma	0.00163	0.00388	CcSEcCtD
Scopolamine—Asthenia—Vincristine—sarcoma	0.00162	0.00387	CcSEcCtD
Scopolamine—Vomiting—Thiotepa—sarcoma	0.00162	0.00386	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—sarcoma	0.00161	0.00384	CcSEcCtD
Scopolamine—Vomiting—Dactinomycin—sarcoma	0.00161	0.00383	CcSEcCtD
Scopolamine—Rash—Thiotepa—sarcoma	0.00161	0.00383	CcSEcCtD
Scopolamine—Dermatitis—Thiotepa—sarcoma	0.00161	0.00383	CcSEcCtD
Scopolamine—Headache—Thiotepa—sarcoma	0.0016	0.00381	CcSEcCtD
Scopolamine—Rash—Dactinomycin—sarcoma	0.0016	0.0038	CcSEcCtD
Scopolamine—Asthenia—Mitoxantrone—sarcoma	0.00158	0.00377	CcSEcCtD
Scopolamine—Fatigue—Etoposide—sarcoma	0.00158	0.00376	CcSEcCtD
Scopolamine—Pain—Etoposide—sarcoma	0.00157	0.00373	CcSEcCtD
Scopolamine—Constipation—Etoposide—sarcoma	0.00157	0.00373	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—sarcoma	0.00157	0.00373	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—sarcoma	0.00156	0.00372	CcSEcCtD
Scopolamine—Sweating—Epirubicin—sarcoma	0.00155	0.00368	CcSEcCtD
Scopolamine—Nausea—Thiotepa—sarcoma	0.00152	0.00361	CcSEcCtD
Scopolamine—Feeling abnormal—Etoposide—sarcoma	0.00151	0.0036	CcSEcCtD
Scopolamine—Nausea—Dactinomycin—sarcoma	0.00151	0.00358	CcSEcCtD
Scopolamine—Dizziness—Vincristine—sarcoma	0.0015	0.00356	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—sarcoma	0.00149	0.00355	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—sarcoma	0.00147	0.00351	CcSEcCtD
Scopolamine—Abdominal pain—Etoposide—sarcoma	0.00145	0.00345	CcSEcCtD
Scopolamine—Body temperature increased—Etoposide—sarcoma	0.00145	0.00345	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—sarcoma	0.00145	0.00345	CcSEcCtD
Scopolamine—Vomiting—Vincristine—sarcoma	0.00144	0.00343	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—sarcoma	0.00144	0.00342	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—sarcoma	0.00143	0.0034	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—sarcoma	0.00143	0.0034	CcSEcCtD
Scopolamine—Rash—Vincristine—sarcoma	0.00143	0.0034	CcSEcCtD
Scopolamine—Dermatitis—Vincristine—sarcoma	0.00143	0.00339	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—sarcoma	0.00142	0.00338	CcSEcCtD
Scopolamine—Headache—Vincristine—sarcoma	0.00142	0.00338	CcSEcCtD
Scopolamine—Vomiting—Mitoxantrone—sarcoma	0.0014	0.00334	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—sarcoma	0.00139	0.00332	CcSEcCtD
Scopolamine—Rash—Mitoxantrone—sarcoma	0.00139	0.00331	CcSEcCtD
Scopolamine—Dermatitis—Mitoxantrone—sarcoma	0.00139	0.00331	CcSEcCtD
Scopolamine—Headache—Mitoxantrone—sarcoma	0.00138	0.00329	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—sarcoma	0.00136	0.00324	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—sarcoma	0.00135	0.00322	CcSEcCtD
Scopolamine—Nausea—Vincristine—sarcoma	0.00134	0.0032	CcSEcCtD
Scopolamine—Flushing—Epirubicin—sarcoma	0.00134	0.0032	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—sarcoma	0.00133	0.00316	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—sarcoma	0.00132	0.00315	CcSEcCtD
Scopolamine—Asthenia—Etoposide—sarcoma	0.00132	0.00313	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—sarcoma	0.00131	0.00312	CcSEcCtD
Scopolamine—Nausea—Mitoxantrone—sarcoma	0.00131	0.00312	CcSEcCtD
Scopolamine—Pruritus—Etoposide—sarcoma	0.0013	0.00309	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—sarcoma	0.00129	0.00308	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—sarcoma	0.00129	0.00307	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—sarcoma	0.00127	0.00302	CcSEcCtD
Scopolamine—Erythema—Epirubicin—sarcoma	0.00126	0.003	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—sarcoma	0.00125	0.00298	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—sarcoma	0.00124	0.00296	CcSEcCtD
Scopolamine—Dizziness—Etoposide—sarcoma	0.00121	0.00289	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—sarcoma	0.0012	0.00285	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—sarcoma	0.00119	0.00283	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—sarcoma	0.00117	0.00279	CcSEcCtD
Scopolamine—Vomiting—Etoposide—sarcoma	0.00117	0.00278	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—sarcoma	0.00117	0.00277	CcSEcCtD
Scopolamine—Agitation—Epirubicin—sarcoma	0.00116	0.00276	CcSEcCtD
Scopolamine—Rash—Etoposide—sarcoma	0.00116	0.00275	CcSEcCtD
Scopolamine—Dermatitis—Etoposide—sarcoma	0.00116	0.00275	CcSEcCtD
Scopolamine—Headache—Etoposide—sarcoma	0.00115	0.00273	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—sarcoma	0.00113	0.00269	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—sarcoma	0.0011	0.00261	CcSEcCtD
Scopolamine—Nausea—Etoposide—sarcoma	0.00109	0.00259	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—sarcoma	0.00107	0.00255	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00107	0.00254	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—sarcoma	0.00105	0.0025	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—sarcoma	0.00105	0.00249	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—sarcoma	0.00104	0.00247	CcSEcCtD
Scopolamine—Oedema—Epirubicin—sarcoma	0.00103	0.00245	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—sarcoma	0.00101	0.0024	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—sarcoma	0.001	0.00239	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—sarcoma	0.000999	0.00238	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—sarcoma	0.000994	0.00237	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000986	0.00235	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—sarcoma	0.000971	0.00231	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—sarcoma	0.000961	0.00229	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—sarcoma	0.000959	0.00228	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—sarcoma	0.000951	0.00226	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—sarcoma	0.000933	0.00222	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—sarcoma	0.000929	0.00221	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—sarcoma	0.000924	0.0022	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—sarcoma	0.00092	0.00219	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—sarcoma	0.000914	0.00218	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—sarcoma	0.000889	0.00212	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—sarcoma	0.000886	0.00211	CcSEcCtD
Scopolamine—Pain—Epirubicin—sarcoma	0.000879	0.00209	CcSEcCtD
Scopolamine—Constipation—Epirubicin—sarcoma	0.000879	0.00209	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—sarcoma	0.000847	0.00202	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—sarcoma	0.000846	0.00201	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—sarcoma	0.00082	0.00195	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—sarcoma	0.000814	0.00194	CcSEcCtD
Scopolamine—Pain—Doxorubicin—sarcoma	0.000814	0.00194	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—sarcoma	0.000813	0.00193	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—sarcoma	0.000813	0.00193	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—sarcoma	0.000784	0.00187	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—sarcoma	0.000752	0.00179	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—sarcoma	0.000752	0.00179	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—sarcoma	0.000738	0.00176	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—sarcoma	0.000727	0.00173	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—sarcoma	0.000683	0.00162	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—sarcoma	0.00068	0.00162	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—sarcoma	0.000673	0.0016	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—sarcoma	0.000654	0.00156	CcSEcCtD
Scopolamine—Rash—Epirubicin—sarcoma	0.000648	0.00154	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—sarcoma	0.000648	0.00154	CcSEcCtD
Scopolamine—Headache—Epirubicin—sarcoma	0.000644	0.00153	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—sarcoma	0.000629	0.0015	CcSEcCtD
Scopolamine—Nausea—Epirubicin—sarcoma	0.000611	0.00145	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—sarcoma	0.000605	0.00144	CcSEcCtD
Scopolamine—Rash—Doxorubicin—sarcoma	0.0006	0.00143	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—sarcoma	0.000599	0.00143	CcSEcCtD
Scopolamine—Headache—Doxorubicin—sarcoma	0.000596	0.00142	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—sarcoma	0.000565	0.00134	CcSEcCtD
